Epilepsy drug may alleviate joint degeneration associated with osteoarthritis

FHS
January 5, 2024
11:56 am

A new study in Nature described Nav1.7 as a key regulatory molecule in cartilage cells and reported the effectiveness of Nav1.7 blockade in reducing pain and slowing progression in OA.

Roche licenses KSQ’s PhI cancer small molecule, with cash infusion to help bankroll biotech’s TIL cell therapies

KSQ Therapeutics quickly lined up another Big Pharma partnership, this time allying with Roche in oncology, and it plans to use the cash windfall to

July 14, 2023

FluoGuide imaging agent wins FDA orphan drug designation for glioma surgery – Pharmaceutical Technology

FlouGuide are expecting Phase IIb trial results by the end of November. Image Credit: Gorodenkoff / Shutterstock. The US Food and Drug Administration (FDA) has

October 4, 2023

Genes that influence pain perception linked to alcohol use disorders

An estimated 16 million people in the United States have alcohol use disorders (AUDs), according to the National Institutes on Alcohol Abuse and Alcoholism (NIAAA).

July 18, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.